» Articles » PMID: 19214207

The Individual Blood Cell Telomere Attrition Rate is Telomere Length Dependent

Overview
Journal PLoS Genet
Specialty Genetics
Date 2009 Feb 14
PMID 19214207
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Age-associated telomere shortening is a well documented feature of peripheral blood cells in human population studies, but it is not known to what extent these data can be transferred to the individual level. Telomere length (TL) in two blood samples taken at approximately 10 years interval from 959 individuals was investigated using real-time PCR. TL was also measured in 13 families from a multigenerational cohort. As expected, we found an age-related decline in TL over time (r = -0.164, P<0.001, n = 959). However, approximately one-third of the individuals exhibited a stable or increased TL over a decade. The individual telomere attrition rate was inversely correlated with initial TL at a highly significant level (r = -0.752, P<0.001), indicating that the attrition rate was most pronounced in individuals with long telomeres at baseline. In accordance, the age-associated telomere attrition rate was more prominent in families with members displaying longer telomeres at a young age (r = -0.691, P<0.001). Abnormal blood TL has been reported at diagnosis of various malignancies, but in the present study there was no association between individual telomere attrition rate or prediagnostic TL and later tumor development. The collected data strongly suggest a TL maintenance mechanism acting in vivo, providing protection of short telomeres as previously demonstrated in vitro. Our findings might challenge the hypothesis that individual TL can predict possible life span or later tumor development.

Citing Articles

Dynamics of Leukocyte Telomere Length in Patients with Fabry Disease.

Levstek T, Breznik N, Vujkovac B, Nowak A, Trebusak Podkrajsek K Biomedicines. 2024; 12(8).

PMID: 39200189 PMC: 11351930. DOI: 10.3390/biomedicines12081724.


Efficacy of a dietary supplement derived from five edible plants on telomere length in Thai adults: A randomized, double-blind, placebo-controlled trial.

Praengam K, Tuntipopipat S, Muangnoi C, Jangwangkorn C, Piamkulvanich O Food Sci Nutr. 2024; 12(3):1592-1604.

PMID: 38455184 PMC: 10916585. DOI: 10.1002/fsn3.3851.


Why and when should organisms elongate their telomeres? Elaborations on the 'excess resources elongation' and 'last resort elongation' hypotheses.

Gomez-Blanco D, Tobler M, Hasselquist D Ecol Evol. 2023; 13(12):e10825.

PMID: 38099139 PMC: 10719541. DOI: 10.1002/ece3.10825.


Involvement of Inheritance in Determining Telomere Length beyond Environmental and Lifestyle Factors.

Gold N, Okeke M, He Y Aging Dis. 2023; 15(6):2470-2490.

PMID: 37962459 PMC: 11567259. DOI: 10.14336/AD.2023.1023.


Leukocyte telomere length and mitochondrial DNA copy number associate with endothelial function in aging-related cardiovascular disease.

Li K, Dai M, Sacirovic M, Zemmrich C, Pagonas N, Ritter O Front Cardiovasc Med. 2023; 10:1157571.

PMID: 37342445 PMC: 10277745. DOI: 10.3389/fcvm.2023.1157571.


References
1.
Han J, Qureshi A, Prescott J, Guo Q, Ye L, Hunter D . A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 2008; 129(2):415-21. PMC: 2632304. DOI: 10.1038/jid.2008.238. View

2.
Teixeira M, Arneric M, Sperisen P, Lingner J . Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell. 2004; 117(3):323-35. DOI: 10.1016/s0092-8674(04)00334-4. View

3.
van Steensel B, de Lange T . Control of telomere length by the human telomeric protein TRF1. Nature. 1997; 385(6618):740-3. DOI: 10.1038/385740a0. View

4.
Graakjaer J, Der-Sarkissian H, Schmitz A, Bayer J, Thomas G, Kolvraa S . Allele-specific relative telomere lengths are inherited. Hum Genet. 2006; 119(3):344-50. DOI: 10.1007/s00439-006-0137-x. View

5.
Bekaert S, De Meyer T, Rietzschel E, De Buyzere M, De Bacquer D, Langlois M . Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell. 2007; 6(5):639-47. DOI: 10.1111/j.1474-9726.2007.00321.x. View